Press release

Siemens Healthineers steps into the future with new corporate governance structure and co-determined supervisory board

Annual Shareholders’ Meeting 2024
Published on April 18, 2024
<ul><li><strong>Co-determined supervisory board will oversee business activities across the company&nbsp;</strong></li><li><strong>Strengthening the company’s co-determination in Germany&nbsp;</strong></li><li><strong>Profitable growth course continued sustainably and successfully in fiscal year 2023&nbsp;</strong></li><li><strong>Proposed dividend of €0.95 per share </strong></li></ul><p>Siemens Healthineers AG shareholders will vote at today’s annual shareholders’ meeting on the composition of the shareholder side of the new, co-determined supervisory board which will comprise a total of 20 members. At the end of 2023, Siemens Healthineers simplified and strengthened its corporate governance structure to reflect its growing importance as a member of Germany’s DAX index.&nbsp;</p><p>“This new structure is leaner, simpler and more effective,” says the chair of the supervisory board, Ralf P. Thomas, in his speech at this year's annual shareholders’ meeting. “More responsibility, more visibility, and a clear profile: This is the direction in which Siemens Healthineers AG has developed since its initial public offering, the merger with Varian and its inclusion in the DAX. In light of this extremely pleasing development, we have taken the logical step of adapting the company’s corporate governance structure to the DAX standard.”&nbsp;</p><p>As early as December 2023, the main business activities of Siemens Healthcare GmbH were transferred to Siemens Healthineers AG to implement a new corporate governance structure. Since then, more than 17,000 employees in Germany are directly employed by Siemens Healthineers AG. For this reason, a co-determined supervisory board must now be formed at the Siemens Healthineers AG level. To date, equal representation has taken place at the level of the Siemens Healthcare GmbH supervisory board. The future co-determined Siemens Healthineers AG supervisory board will monitor business activities across the company and thus strengthen co-determination in Germany.&nbsp;</p><p>Subject to the approval of the annual shareholders’ meeting, the supervisory board will initially consist of 16 members, half being shareholder representatives and half employee representatives. Two additional members from each side will be added once the amendment to the Articles of Association on the enlargement of the supervisory board to 20 members, also to be resolved on at the annual shareholders’ meeting, is entered into the commercial register.&nbsp;</p><p>The ten current members of the supervisory board are standing for re-election as shareholder representatives at the annual shareholders’ meeting. For the employee side, the chair of the general works council, Dorothea Simon, and the political secretary of the IG Metall Bavarian district, Andrea Fehrmann, have, inter alia, been appointed by the court as new members of the supervisory board, effective from the end of the annual shareholders’ meeting.&nbsp;</p><p><strong>Serving patients all over the world </strong></p><p>Bernd Montag, chief executive officer of Siemens Healthineers AG, focused his speech at the annual general meeting on the patients for whom the company’s employees work every day: “Since Siemens Healthineers was listed as an independent company on the Frankfurt Stock Exchange six years ago, there has only been one focus for us: We want to help people stay healthy or become healthy. We help our customers to provide better care for more people – despite increasingly scarce resources. This is the result of unique, trusting partnerships to serve patients around the world,” says Montag.&nbsp;</p><p>The managing board and supervisory board will propose to the annual shareholders’ meeting that a dividend of €0.95 per share be paid for the successful fiscal year 2023. This corresponds to a payout ratio of 70 percent of profit after tax.</p>

Siemens Healthineers 2024

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2023, which ended on September 30, 2023, Siemens Healthineers had approximately 71,000 employees worldwide and generated revenue of around €21.7 billion. Further information is available at